search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


WavSTAT study.


- candidate number9347
- NTR NumberNTR2859
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR18-apr-2011
- Secondary IDsNL36255.018.11 CCMO
- Public TitleWavSTAT study.
- Scientific TitleEvaluation of the WavSTAT Optical Biopsy System for the detection of early neoplasia in the Barrett oesophagus.
- ACRONYMWavSTAT
- hypothesisWe hypothesize that the WavSTAT optical biopsy system may improve the endoscopists ability to detect and distinguish suspicious lesions in the Barrett oesophagus, while reducing the need for extensive biopsy protocols during surveillance endoscopies.
- Healt Condition(s) or Problem(s) studiedEsophageal cancer, Barrett's esophagus, Detection, Endoscopy, Dysplasia
- Inclusion criteria1. Age > 18 80 years;
2. BO with a minimal circumferential length of 2 cm;
3. BO without dysplasia (NDBO) and patients with BO referred for endoscopic work-up of HGIN or EC;
4. Signed informed consent.
- Exclusion criteria1. Prior history of surgical or endoscopic treatment for oesophageal neoplasia;
2. Presence of erosive oesophagitis (Los Angeles classification ≥B);
3. Inability to obtain biopsies (e.g. due to anticoagulation, coagulation disorders, varices);
4. Unable to provide signed informed consent.
- mec approval receivedno
- multicenter trialyes
- randomisedno
- groupFactorial
- TypeSingle arm
- Studytypeobservational
- planned startdate 1-mei-2011
- planned closingdate1-sep-2012
- Target number of participants170
- InterventionsPhase 1: Development of algorithm for the WavSTAT system in 20 patients;
Phase 2: Validation of the WavSTAT system in 150 patients.
- Primary outcomePhase 1 will be used to develop a tissue recognition algorithm by correlating the measured fluorescence spectra to the histology of the corresponding tissue.

In phase 2 the WavSTAT optical biopsy will be validated and assessed for the following outcome parameters:
1. Sensitivity and specificity of WavSTAT for the detection of early Barrett neoplasia (HGIN/EC);
2. Additional value of WavSTAT to standard inspection with WLE, compared to inspection with WLE alone for the detection of early Barrett neoplasia (HGIN/EC).
- Secondary outcomeN/A
- TimepointsPhase 1 start: May 1st 2011;
Phase 1 stop: Sept 1st 2011.

Phase 2 start: Jan 1st 2012;
Phase 2 stop: Sept 1st 2012.
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIES David Boerwinkel
- CONTACT for SCIENTIFIC QUERIESProf. dr. J.J.G.H.M. Bergman
- Sponsor/Initiator Academic Medical Center (AMC), Amsterdam
- Funding
(Source(s) of Monetary or Material Support)
SpectraScience, San Diego, CA, USA
- PublicationsN/A
- Brief summaryAims:
1. To investigate the WavSTAT optical biopsy system by collecting fluorescence spectra of non-dysplastic and dysplastic Barrett mucosa and correlate these to the histology. The integrated optical/physical biopsy forceps will ensure spot-on correlation. The results of this study will be used to develop a differentiating, tissue recognition algorithm;
2. In a second validation study, the algorithm is integrated in the system and patients with a Barrett oesophagus will be investigated by standard white light endoscopy and with the WavSTAT optical biopsy system to assess the additional value of this differentiation tool for the detection of early neoplasia in BO.
- Main changes (audit trail)
- RECORD18-apr-2011 - 25-apr-2011


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl